Search results
Results from the Health.Zone Content Network
On March 30, HHS announced the first grant to a vaccine in development with $456 million allocated to Johnson & Johnson. Additional funds were approved for Moderna, AstraZeneca, Regeneron, Novavax, Pfizer, and a partnership between Sanofi and GlaxoSmithKline. The program's timeline was formally announced on May 15.
sore throat. shortness of breath. headache. diarrhea. loss of taste or smell. For most people who get COVID-19, these symptoms go away with time, just like with any viral infection. But there are ...
Nausea. Increased thirst and urination. Poor appetite. Constipation. Weakness. Confusion. Ataxia, a neurological condition that causes you to slur or stumble. WebMD explores what the research says ...
Since the original deployment following Hurricane Katrina, FMSs have been deployed to support other major disaster responses including Superstorm Sandy. The FMS program is a collaboration between CDC and the Office of Emergency Management under the HHS Assistant Secretary for Preparedness and Response. In 2014, responding to stakeholder ...
In February 2021, after conducting part of their study, the WHO stated that the likely origin of COVID-19 was a zoonotic event from a virus circulating in bats, likely through another animal carrier, and that the time of transmission to humans was likely towards the end of 2019.
Here are 15 supplements that are known for their immune-boosting potential. Yaroslav Danylchenko/Stocksy United. 1. Vitamin D. Vitamin D is a fat-soluble nutrient essential to the health and ...
In February 2021, the coronavirus committee asked the Biden administration for documents relating to the Trump administration's handling of the coronavirus pandemic, saying that Trump's HHS and other officials had blocked requests for documents and staff testimony in spite of "two subpoenas and at least 20 document requests."
t. e. The Access to COVID-19 Tools Accelerator (ACT Accelerator or ACT-A), or the Global Collaboration to Accelerate the Development, Production and Equitable Access to New COVID-19 diagnostics, therapeutics and vaccines, is a G20 initiative announced by pro-tem Chair Mohammed al-Jadaan on 24 April 2020. [1]